AbbVie’s 3 For 3

Ashley Hayes

Published on: 15/06/2020

Drugmaker AbbVie scored three big wins in recent days – one in the courtroom, one in a clinical study, and one in the form of a collaboration deal. And these

AbbvieHealth StocksInvestInvestingStocks2020 Stock PicksCoronavirusCOVID-19 PandemicHealth StocksInvestInvestingInvestorsStock Market

What About AbbVie?

Ashley Hayes

Published on: 11/05/2020

Pharmaceutical giant AbbVie has weathered the COVID-19 storm relatively well, with its first-quarter revenue and earnings per share both coming in ahead of

AbbvieCOVID-19DividendsEarningsInvestRevenueStock MarketStocks2020 Stock PicksCoronavirusCoronavirus PandemicCOVID-19 PandemicStock MarketStock PicksStocks to Watch